MetaCap

Fennec Pharmaceuticals (FENC) vs Tectonic Therapeutic (TECX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Fennec Pharmaceuticals (FENC) has outperformed Tectonic Therapeutic (TECX) over the past year, gaining 66.1% versus a gain of 8.1%. Over five years, FENC leads with a +35.8% price change compared with -57.7% for TECX. Fennec Pharmaceuticals is the larger company by market cap ($462.1 million vs $405.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FENC+66.12%TECX+8.08%
+104%+35%-33%
Nov 21, 20251 yearNov 20, 2026
FENC+33.23%TECX-59.45%
+40%-32%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FENC versus TECX key metrics
MetricFENCTECX
Share price$13.09$20.73
Market cap$462.14M$405.26M
1-day change-2.68%-1.47%
YTD return+70.00%-0.62%
1-year return+66.12%+8.08%
5-year return+35.79%-57.66%
P/E ratio (TTM)436.33—
Forward P/E12.47—
EPS (TTM)$0.03$-4.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.64M—
Revenue growth (YoY)-6.09%—
Net income (latest FY)$-9.74M$-74.15M
Operating margin-14.07%—
Net margin-21.82%—
52-week high$13.85$39.53
52-week low$5.65$16.77
Distance from 52-week high-5.49%-47.56%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+34.45%+242.50%
Average volume220.87K212.16K
Shares outstanding35.31M19.55M
Employees3560
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FENC has outperformed TECX by 58.0 percentage points over the past year.

About Fennec Pharmaceuticals

FENC stock →

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 35 employees

About Tectonic Therapeutic

TECX stock →

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees

FENC vs TECX FAQ

Which is bigger, Fennec Pharmaceuticals or Tectonic Therapeutic?

Fennec Pharmaceuticals (FENC) is larger, with a market capitalization of $462.14M compared with $405.26M for Tectonic Therapeutic (TECX).

Which stock has performed better over the past year, FENC or TECX?

FENC returned +66.12% over the past 12 months, compared with +8.08% for TECX (price return, excluding dividends). Past performance does not predict future results.

Are Fennec Pharmaceuticals and Tectonic Therapeutic in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons